HIRSCHMAN ORIN 13D and 13G filings for Immix Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-29 06:17 am Sale | 2024-12-31 | 13G | Immix Biopharma, Inc. IMMX | HIRSCHMAN ORIN | 0 0.000% | -1,455,000 (Position Closed) | Filing |
| 2024-02-07 09:18 am Purchase | 2024-02-06 | 13G | Immix Biopharma, Inc. IMMX | HIRSCHMAN ORIN | 1,455,000 5.800% | 1,455,000 (New Position) | Filing |